Spread the love

PIB’S BULLETIN ON COVID-19

https://static.pib.gov.in/WriteReadData/userfiles/image/image0020FX3.png
https://static.pib.gov.in/WriteReadData/userfiles/image/image001BPSF.jpg
Over 90 Crore vaccine doses have been administered so far under Nationwide Vaccination Drive24,354 new cases in the last 24 hoursActive cases account for less than 1% of total cases, currently at 0.81%; Lowest since March 2020India’s Active caseload stands at 2,73,889; lowest in 197 daysRecovery Rate currently at 97.86%; Highest since March 202025,455 recoveries in the last 24 hours increases Total Recoveries to 3,30,68,599Weekly Positivity Rate (1.68%) less than 3% for last 99 daysDaily positivity rate (1.70%) less than 3% for last 33 days57.19 cr Total Tests conducted so far

       #Unite2FightCorona                                                                                    #IndiaFightsCorona

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION & BROADCASTING

GOVERNMENT OF INDIA

Image

COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage exceeds 90 Cr Mark

More than 69.33Lakh doses administered in the last 24 hours

Recovery Rate currently at 97.86%; Highest since March 2020

24,354 New Cases reported in the last 24 hours

India’s Active Caseload (2,73,889) is 0.81% of Total Cases

Weekly Positivity Rate (1.68%) less than 3% for last 99 days

India’s Cumulative COVID-19 Vaccination Coverage exceeds 90 Cr Mark. With the administration of 69,33,838 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 89.74Cr (89,74,81,554) as per provisional reports till 7 am today. This has been achieved through 87,06,441 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

 HCWs1st Dose1,03,73,287
2nd Dose89,07,790
 FLWs1st Dose1,83,54,007
2nd Dose1,50,47,392
 Age Group 18-44 years1st Dose36,35,39,734
2nd Dose8,51,18,303
 Age Group 45-59 years1st Dose16,03,02,227
2nd Dose7,75,18,029
 Over 60 years1st Dose10,17,62,489
2nd Dose5,65,58,296
Total89,74,81,554

The recovery of25,455patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,30,68,599.

Consequently, India’s recovery rate stands at 97.86%. Recovery Rate is currently at its highest peak since March 2020.

https://static.pib.gov.in/WriteReadData/userfiles/image/image002WWVX.jpg

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 97 consecutive days now.

24,354new cases were reported in the last 24 hours.

https://static.pib.gov.in/WriteReadData/userfiles/image/image003HGC8.jpg

The Active Caseload is presently2,73,889, which is the lowest in 197 days.Active cases presently constitute 0.81% of the country’s total Positive Cases.

https://static.pib.gov.in/WriteReadData/userfiles/image/image004O2ZW.jpg

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of

14,29,258tests being conducted. India has so far conducted over 57.19 Cr (57,19,94,990) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.68% remains less than 3% for the last 99 days now. The Daily Positivity rate reported to be1.70%. The daily Positivity rate has remained below3% for last 33 days and below 5% for 116 consecutive days now.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1760213

Update on COVID-19 Vaccine Availability in States/UTs

More than 88.14Crore vaccine doses provided to States/UTs

More than 5.28 Crore balance and unutilized vaccine doses still available with States/UTs

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccinemanufacturers in the country to States and UTs.

 VACCINE DOSES (As on 2ndOctober 2021)
 SUPPLIED 88,14,50,515
 BALANCE AVAILABLE  5,28,28,050

More than 88.14 crore (88,14,50,515) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.

More than5.28Cr (5,28,28,050) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1760217

Important Tweetshttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-0&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444273923189735427&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550pxhttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-1&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444212503165104129&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550pxhttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-2&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444140018881105929&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550pxhttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-3&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444260122247634952&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550pxhttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-4&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444176463314309124&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550pxhttps://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-5&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1444166521484242950&lang=en&origin=https%3A%2F%2Fpib.gov.in%2FPressReleasePage.aspx%3FPRID%3D1760424&sessionId=49c40efff0eb8ac4e84ce4374e7d8e0762337be5&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550px


Spread the love

By udaen

Leave a Reply

Your email address will not be published. Required fields are marked *